Pharmacogenetics for severe adverse drug reactions induced by molecular-targeted therapy.

Abstract excerpt

Molecular-targeted drugs specifically interfere with molecules that are frequently overexpressed or mutated in cancer cells. As such, these drugs are generally considered to precisely attack cancer cells, thereby inducing fewer adverse drug reactions (ADRs). However, molecular-targeted drugs can still cause characteristic ADRs that, although rarely severe, can be life-threatening. Therefore, it is becoming...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Related Side Effects and Adverse Reactions
• Share to Genetic Variation
• Share to Molecular Targeted Therapy